Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Autophagy: A new strategy for host-directed therapy of tuberculosis
Seungwha Paik, Jin Kyung Kim, Chaeuk Chung, et al.
Virulence (2018) Vol. 10, Iss. 1, pp. 448-459
Open Access | Times Cited: 136

Showing 26-50 of 136 citing articles:

Dimethyl itaconate is effective in host-directed antimicrobial responses against mycobacterial infections through multifaceted innate immune pathways
Young Jae Kim, Eun Jin Park, Sang-Hee Lee, et al.
Cell & Bioscience (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 15
Deficiency in the autophagy modulator Dram1 exacerbates pyroptotic cell death of Mycobacteria-infected macrophages
Rui Zhang, Mónica Varela, Gabriel Forn‐Cuní, et al.
Cell Death and Disease (2020) Vol. 11, Iss. 4
Open Access | Times Cited: 34
Targeted Pulmonary Delivery of the Green Tea Polyphenol Epigallocatechin Gallate Controls the Growth of Mycobacterium tuberculosis by Enhancing the Autophagy and Suppressing Bacterial Burden
Ankur Sharma, Kalpesh Vaghasiya, Eupa Ray, et al.
ACS Biomaterials Science & Engineering (2020) Vol. 6, Iss. 7, pp. 4126-4140
Closed Access | Times Cited: 33
Targeting Molecular Inflammatory Pathways in Granuloma as Host-Directed Therapies for Tuberculosis
Reto Guler, Mumin Ozturk, Solima Sabeel, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 31
Subunit Vaccine ESAT-6:c-di-AMP Delivered by Intranasal Route Elicits Immune Responses and Protects Against Mycobacterium tuberculosis Infection
Huanhuan Ning, Wei Zhang, Jian Kang, et al.
Frontiers in Cellular and Infection Microbiology (2021) Vol. 11
Open Access | Times Cited: 28
Differential Requirement for IRGM Proteins during Tuberculosis Infection in Mice
Kaley M. Wilburn, Rachel Meade, Emma M Heckenberg, et al.
Infection and Immunity (2023) Vol. 91, Iss. 2
Open Access | Times Cited: 11
Harnessing host-pathogen interactions for innovative drug discovery and host-directed therapeutics to tackle tuberculosis
Sapna Saini, Anjali Gangwar, Rashmi Sharma
Microbiological Research (2023) Vol. 275, pp. 127466-127466
Open Access | Times Cited: 11
Immune-endocrine crossroads: the impact of nuclear receptors in Tuberculosis and Chagas disease
Ana Rosa Pérez, Óscar Bottasso, Natalia Santucci
Frontiers in Endocrinology (2025) Vol. 16
Open Access
Increased autophagy activity regulated by LC3B gene promoter DNA methylation is associated with progression to active pulmonary tuberculosis disease
Yung-Che Chen, Ying-Tang Fang, Chao-Chien Wu, et al.
Respiratory Research (2025) Vol. 26, Iss. 1
Open Access
Host Immunity and Intracellular Bacteria Evasion Mechanisms: Enhancing Host-Directed Therapies with Drug Delivery Systems
Jiayang Cai, Han Zhou, Mingwei Liu, et al.
International Journal of Antimicrobial Agents (2025), pp. 107492-107492
Closed Access
Innovative Strategies for Combating Multidrug-Resistant Tuberculosis: Advances in Drug Delivery Systems and Treatment
Omobolanle A. Omoteso, Adewale Oluwaseun Fadaka, Roderick B. Walker, et al.
Microorganisms (2025) Vol. 13, Iss. 4, pp. 722-722
Open Access
The anti-tubercular activity of simvastatin is mediated by cholesterol-driven autophagy via the AMPK-mTORC1-TFEB axis
Natalie Bruiners, Noton K. Dutta, Valentina Guerrini, et al.
Journal of Lipid Research (2020) Vol. 61, Iss. 12, pp. 1617-1628
Open Access | Times Cited: 32
Tuberculosis: An Update on Pathophysiology, Molecular Mechanisms of Drug Resistance, Newer Anti-TB Drugs, Treatment Regimens and Host- Directed Therapies
Pobitra Borah, Pran Kishore Deb, Katharigatta N. Venugopala, et al.
Current Topics in Medicinal Chemistry (2020) Vol. 21, Iss. 6, pp. 547-570
Closed Access | Times Cited: 31
Novel Treatments against Mycobacterium tuberculosis Based on Drug Repurposing
Álvaro Mourenza, José A. Gil, Luís M. Mateos, et al.
Antibiotics (2020) Vol. 9, Iss. 9, pp. 550-550
Open Access | Times Cited: 29
Potential of Neuroinflammation-Modulating Strategies in Tuberculous Meningitis: Targeting Microglia
Huan-Jun Lu, Daji Guo, Qian-Qi Wei
Aging and Disease (2023)
Open Access | Times Cited: 9
TRIM27 elicits protective immunity against tuberculosis by activating TFEB-mediated autophagy flux
Dongdong Zhao, Lihua Qiang, Zehui Lei, et al.
Autophagy (2024) Vol. 20, Iss. 7, pp. 1483-1504
Closed Access | Times Cited: 3
Nanomaterial-mediated host directed therapy of tuberculosis by manipulating macrophage autophagy
Yilin Liu, Jiajun Wang, Jiayi Yang, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 3
The roles of microRNAs in regulation of autophagy during bacterial infection
Prashanta Silwal, Yi Sak Kim, Joyoti Basu, et al.
Seminars in Cell and Developmental Biology (2019) Vol. 101, pp. 51-58
Closed Access | Times Cited: 29
AMPK-Targeted Effector Networks in Mycobacterial Infection
Eun‐Kyeong Jo, Prashanta Silwal, Jae‐Min Yuk
Frontiers in Microbiology (2019) Vol. 10
Open Access | Times Cited: 28
NSC 18725, a Pyrazole Derivative Inhibits Growth of Intracellular Mycobacterium tuberculosis by Induction of Autophagy
Garima Arora, Gagandeep, Assirbad Behura, et al.
Frontiers in Microbiology (2020) Vol. 10
Open Access | Times Cited: 25
From infection niche to therapeutic target: the intracellular lifestyle of Mycobacterium tuberculosis
Leah Rankine-Wilson, Tirosh Shapira, Carine Sao Emani, et al.
Microbiology (2021) Vol. 167, Iss. 4
Open Access | Times Cited: 22
Autophagy and Host Defense in Nontuberculous Mycobacterial Infection
Prashanta Silwal, In Soo Kim, Eun‐Kyeong Jo
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 21
A selective PPM1A inhibitor activates autophagy to restrict the survival of Mycobacterium tuberculosis
Stefania Berton, Lu Chen, Yi Chu Liang, et al.
Cell chemical biology (2022) Vol. 29, Iss. 7, pp. 1126-1139.e12
Open Access | Times Cited: 14
Berbamine promotes macrophage autophagy to clear Mycobacterium tuberculosis by regulating the ROS/Ca 2+ axis
Su Zhang, Xuefeng Zhou, Min Ou, et al.
mBio (2023)
Open Access | Times Cited: 9
Regulatory Mechanisms of Autophagy-Targeted Antimicrobial Therapeutics Against Mycobacterial Infection
Prashanta Silwal, Seungwha Paik, Jin Kyung Kim, et al.
Frontiers in Cellular and Infection Microbiology (2021) Vol. 11
Open Access | Times Cited: 20

Scroll to top